| |
| |
|
| Insider
Information: |
Sear Timothy R G |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
87,668 |
|
|
Indirect Shares
|
150,000 |
|
|
| Direct
Value |
$15,646 |
|
|
|
Indirect Value
|
$51,390 |
|
|
| Total
Shares |
237,668 |
|
|
| Total
Value |
$67,036 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Director |
2013-01-01 |
45,668 |
2013-01-01 |
150,000 |
Premium* |
|
|
Sigma-Aldrich Corp |
SIAL |
Director |
2010-01-07 |
42,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-04-01 |
4 |
A |
$3.35 |
$11,250 |
D/D |
3,358 |
191,551 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-01-01 |
4 |
A |
$2.65 |
$9,750 |
D/D |
3,679 |
95,463 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-04-01 |
4 |
A |
$2.57 |
$9,750 |
D/D |
3,794 |
99,257 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2005-03-14 |
4 |
B |
$10.00 |
$50,037 |
D/D |
5,000 |
20,787 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2005-05-09 |
4 |
A |
$9.56 |
$48,812 |
D/D |
5,000 |
26,336 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2005-05-17 |
4 |
B |
$9.61 |
$48,176 |
D/D |
5,000 |
31,336 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-05-07 |
4 |
A |
$19.81 |
$99,271 |
D/D |
5,000 |
100,111 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-11-23 |
4 |
B |
$14.25 |
$71,384 |
D/D |
5,000 |
140,200 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2006-11-10 |
4 |
B |
$12.10 |
$85,883 |
D/D |
7,048 |
91,634 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2006-09-08 |
4 |
B |
$9.12 |
$71,952 |
D/D |
7,845 |
81,890 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-07-27 |
4 |
OE |
$14.62 |
$136,463 |
D/D |
9,334 |
109,754 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-11-26 |
4 |
B |
$14.13 |
$142,416 |
D/D |
10,000 |
150,200 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-08-13 |
4 |
B |
$3.15 |
$31,470 |
D/D |
10,000 |
69,167 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-08-11 |
4 |
B |
$2.98 |
$59,520 |
D/D |
20,000 |
39,167 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-08-12 |
4 |
B |
$3.04 |
$60,880 |
D/D |
20,000 |
59,167 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-08-17 |
4 |
B |
$3.14 |
$62,880 |
D/D |
20,000 |
89,167 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2007-11-21 |
4 |
B |
$13.94 |
$353,831 |
D/D |
25,000 |
135,200 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2009-01-27 |
4 |
B |
$10.37 |
$259,250 |
D/D |
25,000 |
183,640 |
2.39 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
|
– • – |
2009-08-20 |
4 |
OE |
$29.72 |
$939,350 |
D/D |
30,000 |
40,800 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2011-08-04 |
4 |
B |
$3.67 |
$110,220 |
D/D |
30,000 |
130,718 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2005-10-11 |
4 |
B |
$7.80 |
$312,000 |
D/D |
40,000 |
72,376 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2012-12-14 |
4 |
B |
$4.33 |
$216,350 |
I/I |
50,000 |
150,000 |
2.1 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2010-05-27 |
4 |
S |
$2.05 |
$359,435 |
D/D |
(175,334) |
16,217 |
0 |
- |
|
73 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
